Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aratana Therapeutics Inc (NASDAQ:PETX)

9.07
Delayed Data
As of Aug 26
 +0.03 / +0.33%
Today’s Change
2.56
Today|||52-Week Range
19.99
+62.54%
Year-to-Date
No recent news for Aratana Therapeutics Inc.

Today’s Trading

Previous close9.04
Today’s open9.09
Day’s range8.90 - 9.19
Volume602,892
Average volume (3 months)726,613
Market cap$321.2M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-88.46%
Earnings growth (this year)+68.50%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-11.60%
P/E ratioNM
Price/Sales282.75
Price/Book3.09

Competitors

 Today’s
change
Today’s
% change
ARLZAralez Pharmaceutica...+0.05+1.00%
AKBAAkebia Therapeutics ...+0.02+0.25%
SVASinovac Biotech Ltd+0.02+0.34%
PRTKParatek Pharmaceutic...+0.10+0.75%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$678.0K
Annual profit (last year)-$84.1M
Net profit margin-12,397.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Operating Officer
Brent A. Standridge
Corporate headquarters
Leawood, Kansas

Forecasts

Partner Offers

Search for Jobs